Pharmafile Logo
Pharmafocus logo
Advanced Search

Cellbyte raises $2.75m to fund pharma drug launch platform

November 27, 2025
Product launch AI, Cellbyte, biotech

Cellbyte has announced that it has raised $2.75m in seed funding for the streamlining of pharmaceutical drug launches. The complexity …

News

Accession Therapeutics doses first patient in new cancer immunotherapy trial

November 26, 2025
Research and Development Accession Therapeutics, Oncology

Biopharmaceutical company Accession Therapeutics has announced the dosing of the first patient in the phase 1 clinical trial of TROCEPT-01 …

News
Press release

ViVac Pharma appoints Keren Leshem as CEO

November 26, 2025
CEO, Oncology, ViVac Pharma

Early-stage biotechnology company ViVac Pharma has appointed Keren Leshem as its new CEO. Leshem brings almost 30 years of experience …

Appointment

Alvotech biosimilar receives EC marketing approval

November 26, 2025
Research and Development Alvotech, Immunology, Inflammatory disease, Rheumatology

The European Commission (EC) has granted marketing authorisation for Gobivaz, Alvotech’s first-in-market biosimilar of Simponi (golimumab), which is used for …

News

A community-first future: which pathways will get us there?

November 21, 2025
Business Services Gateway to Local Adoption, NHS, Visions4Health, pharmacy

In the final Gateway to Local Adoption article of 2025, Visions4Health caught up with Julian Wenman, senior operations manager in …

Feature
partnership

Scitech Engineering joins Ekium Group, rebrands as Scitech-EKIUM

November 21, 2025
Manufacturing and Production Ekium Group, Engineering, Good Manufacturing Production, Scitech Engineering, automation

Scitech Engineering, a provider of engineering and manufacturing services across multiple industries including life sciences, has joined the Ekium Group, …

News

M42 and Olive Rock agree ownership of UAE health assets

November 20, 2025
Business Services M42, Olive Rock, UAE health assets

Global health company M42 and private equity firm Olive Rock Partners (ORP) have signed an agreement that will see the …

News

iZafe Group signs agreement with Skand for automated medication dispenser

November 20, 2025
Business Services Skand, iZafe Group

iZafe Group have signed a distribution agreement with Skand for the launch of Dosell, a medication-dispensing robot, in Iceland. Dosell …

News
drug-trials

BioNet receives positive EMA opinion on new pertussis vaccine

November 19, 2025
Research and Development BioNet, Vaccine

BioNet has received a positive opinion from the Committee for Medicinal Products for Human Use of the European Medicines Agency …

News

1nhaler receives £1.5m in funding to develop new cardboard inhaler

November 19, 2025
Research and Development 1nhaler, asthma

1nhaler, a Scotland-based developer of drug delivery devices, has received £1.5m in seed funding for the development of its new …

News
hsm_mobile_clinical_trial_istock-872676342

Molnlycke donates risk prediction patent to SKF’s digital patent platform

November 14, 2025
Business Services Digital Platforms, Mölnlycke, SKF, The Patent Bay

Mölnlycke Health Care, a medtech company specialising in wound care and surgical solutions, has donated a risk prediction patent to …

News
brain_anatomy_medical_head_skull_digital_3_d_x_ray_xray_psychedelic_3720x2631

Study finds at-home brain stimulation therapies reduce depression relapse rate

November 14, 2025
Research and Development Brain Stimulation Therapies, Flow Neuroscience, Transcranial Direct Current Stimulation Therapy, depression

A new study published in the Journal of Affective Disorders has found that home-based, transcranial, direct current stimulation (tDCS) therapy, …

News

Smurfit Westrock unveils new clinical packaging facility at Dublin Airport

November 13, 2025
Medical Communications Dublin, Smurfit Westrock, clinical packaging facility

Smurfit Westrock has inaugurated the first-of-its-kind adherence and clinical packaging facility, reinforcing Ireland’s role at the forefront of global healthcare. …

News

EVerZom enters research and licensing agreement with GENFIT

November 13, 2025
Research and Development EVerZom, Eviv, GENFIT, Liver Diseases, collaboration, licensing agreement

EVerZom, a French biotech company developing exosome-based therapies for regenerative medicine, has entered into a research and licensing agreement with …

News
drug-trials

University of Birmingham scientists develop new MRI contrast agent

November 12, 2025
Research and Development Diagnostics, MRI, University of Birmingham, medical imaging

Researchers at the University of Birmingham, UK, have developed a new class of magnetic resonance imaging (MRI) contrast agents that …

News

Custom Pharmaceuticals launches new company for drug product development

November 12, 2025
Business Services Centrix Pharma Solutions, Company Launch, Custom Pharmaceuticals, collaboration, drug development, university of sussex

Customs Pharmaceuticals, a full-service contract development and manufacturing organisation (CDMO), has launched Centrix Pharma Solutions, a new company targeting faster …

News

Novartis receives SMC approval for early breast cancer treatment

November 11, 2025
Research and Development Novartis, Scottish Medicines Consortium, breast cancer, nhs scotland

Novartis has announced that its treatment for early breast cancer, Kisqali (ribociclib), has received approval for use within NHS Scotland …

News

Chiesi expands La Chaussée-Saint-Victor site to manufacture next-gen inhalers

November 10, 2025
Manufacturing and Production Chiesi, Metered Dose Inhalers, Site Expansion, respiratory diseases

Chiesi, a biopharma group focused on treating respiratory diseases, has inaugurated an expansion of its manufacturing and industrial site in …

News

Richmond Pharmacology appoints Dr Edward Jackson as Medical Director

November 7, 2025
CRO, Richmond Pharmacology, biotech, clinical trials

Richmond Pharmacology, a contract research organisation (CRO) specialising in first-in-human and adaptive clinical trials, has appointed Dr Edward Jackson as …

Appointment

Vesper Bio reports positive topline results for dementia candidate

November 7, 2025
Research and Development Frontotemporal degeneration, Vesper Bio, clinical trials, dementia

Vesper Bio, a clinical-stage biotech developing novel oral therapies for neurodegenerative and neuropsychiatric disorders, has reported positive topline data from …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026